Ascites is the buildup of fluid in the abdominal cavity, which often develops as a complication of liver disease. However, ...

Attempts to obtain more lasting relief from ascites have been many and varied. In 1896 Drummond and Morison 1 reported the first surgical treatment of ascites. Talma, 2 in 1898, is usually ...

Background: Ascites and pleural effusion are well recognized complications of pancreatic diseases. Drug therapy of these is limited by high cost, prolonged hospitalization and failure rates ...

J Gastroenterol Hepatol. 2009;24(9):1494-1503. With the application of molecular approaches, efforts towards measuring the bacterial load using DNA in SBP patients have recently been made ...

Ascites is the most common complication of cirrhosis and a major cause of morbidity and hospitalization. Treatment of ascites is initially based on diuretics, but randomized studies assessing the ...

Ascites can develop in patients with cirrhosis as a result of disturbed fluid and electrolyte balance. Not all patients with ascites respond to spironolactone, which is the standard treatment for ...

EMA committee recommends approval of LINDIS Biotech’s Korjuny to treat malignant ascites MA in adults with EpCAM-positive carcinomas: Munich, Germany Wednesday, October 23, 2024 ...

The patent supports BioVie’s liquid formulation of terlipressin for development of a more patient-centric ambulatory treatment regimen for patients with ascites and hepatic failure in the US.